peritoneal cancer
Elahere Fully Approved for Certain Ovarian, Fallopian Tube or Primary Peritoneal Cancer
The FDA approved mirvetuximab soravtansine-gynx (Elahere, ImmunoGen, Inc. [now a part of AbbVie]) for adult ...
MARCH 25, 2024
FDA Grants New Indication for Rubraca
The FDA granted a new indication for Rubraca for the maintenance treatment of recurrent ovarian, fallopian tube or ...
APRIL 6, 2018
Load more